PATENT CLAIM ANALYSIS

Application Number: 16141914
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "009360"]

Abstract:
The present invention relates to variable domains of a camelid heavy-chain antibodies directed against a phosphorylated tau protein and conjugates thereof. The present invention also relates to the use of these domains or conjugates for treating or diagnosing disorders mediated by neurofibrillary tangles, neuropil threads or dystrophic neurites, such as tauopathies.

Claim (Index 42):
The isolated VHH variant according to  claim 36 , characterized in that it consists in the amino acid sequence of SEQ ID NO. 15.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.30952
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15114324', '15035582', '15207836', '15645442', '12792810']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7100180871219005
- 35 USC 102 Novelty (BERT): 0.6206840382103718
- Combined Prediction Score: 0.7010846822307476
- Mean Citation Score: 376.220888
- Max Citation Score: 706.3625
- Similarity Product: 465.1503271915018

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test